Trial
NCT01398124
Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Milton S. Hershey Medical Center
Collaborators
—
Condition
Non-small Cell Lung Cancer
Intervention
Cyclin B1 Peptide
Why stopped
We will not be pursuing this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-22